Sex differences in CKD-associated mortality from 1990 to 2019: data from the global burden of disease study
File(s)1-s2.0-S2590059522001571-main.pdf (1.04 MB)
Published version
Author(s)
Hockham, Carinna
Schanschieff, Florence
Woodward, Mark
Type
Journal Article
Abstract
Abstract
Rationale & Objective: Previous studies have shown chronic kidney disease (CKD) mortality rates to be lower in females than males. We aimed to examine the extent to which sex differences vary over time, among countries and with age, using Global Burden of Disease (GBD) Study data.
Study Design: Observational epidemiological study
Setting & Participants: GBD Study, which used published literature, vital registration systems, kidney replacement therapy registries and household surveys.
Exposures: Sex
Outcomes: CKD-associated mortality rate (per 100,000 population)
Analytical Approach: Changes in CKD mortality between 1990 and 2019 were compared between sexes, globally and for the 50 most populous countries. For 2019 only, sex differences in age-standardised and age-specific mortality were compared among countries.
Results: There was no change in global age-standardised mortality in either sex between 1990 and 2019, with female mortality consistently 30% lower than male mortality. Percentage changes were less favourable in females than males in two-thirds of the 50 countries examined, with the greatest change disparities observed in Egypt, Thailand and Malaysia. In Mexico, which had the greatest overall percentage increase, the increase was smaller in females (81% vs 138%). Female mortality varied between 47% lower and 60% higher than males (in Angola and Egypt, respectively) in 2019. In most countries, female mortality was lower across all age groups, with no narrowing of sex differences with age.
Limitations: We were not able to assess sex differences according to CKD stage, nor did we explore other disease metrics (e.g. disability-adjusted life years).
Conclusions: Percentage changes in age-standardised CKD mortality have tended to be less favourable in females compared to males, but with some notable exceptions. Similarly, whilst female mortality is generally lower than in males, numerous examples exist where the opposite is true. Country-specific assessments of sex differences in CKD-associated outcomes are essential for equitable care.
Rationale & Objective: Previous studies have shown chronic kidney disease (CKD) mortality rates to be lower in females than males. We aimed to examine the extent to which sex differences vary over time, among countries and with age, using Global Burden of Disease (GBD) Study data.
Study Design: Observational epidemiological study
Setting & Participants: GBD Study, which used published literature, vital registration systems, kidney replacement therapy registries and household surveys.
Exposures: Sex
Outcomes: CKD-associated mortality rate (per 100,000 population)
Analytical Approach: Changes in CKD mortality between 1990 and 2019 were compared between sexes, globally and for the 50 most populous countries. For 2019 only, sex differences in age-standardised and age-specific mortality were compared among countries.
Results: There was no change in global age-standardised mortality in either sex between 1990 and 2019, with female mortality consistently 30% lower than male mortality. Percentage changes were less favourable in females than males in two-thirds of the 50 countries examined, with the greatest change disparities observed in Egypt, Thailand and Malaysia. In Mexico, which had the greatest overall percentage increase, the increase was smaller in females (81% vs 138%). Female mortality varied between 47% lower and 60% higher than males (in Angola and Egypt, respectively) in 2019. In most countries, female mortality was lower across all age groups, with no narrowing of sex differences with age.
Limitations: We were not able to assess sex differences according to CKD stage, nor did we explore other disease metrics (e.g. disability-adjusted life years).
Conclusions: Percentage changes in age-standardised CKD mortality have tended to be less favourable in females compared to males, but with some notable exceptions. Similarly, whilst female mortality is generally lower than in males, numerous examples exist where the opposite is true. Country-specific assessments of sex differences in CKD-associated outcomes are essential for equitable care.
Date Issued
2022-10
Date Acceptance
2022-08-10
Citation
Kidney Medicine, 2022, 4 (10), pp.1-10
ISSN
2590-0595
Publisher
Elsevier BV
Start Page
1
End Page
10
Journal / Book Title
Kidney Medicine
Volume
4
Issue
10
Copyright Statement
© 2022 The Authors.
Published by Elsevier Inc.
on behalf of the National
Kidney Foundation, Inc. This
is an open access article
under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Published by Elsevier Inc.
on behalf of the National
Kidney Foundation, Inc. This
is an open access article
under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Identifier
https://www.sciencedirect.com/science/article/pii/S2590059522001571?via%3Dihub
Subjects
Chronic kidney disease
females
males
mortality
sex differences
Publication Status
Published
Article Number
100535
Date Publish Online
2022-08-19